Anna Berkenblit - SVP & CHIEF MEDICAL OFFICER at ImmunoGen, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Svp & Chief Medical Officer
Issuer Symbol
IMGN
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Anna Berkenblit since 08 Jan 2025

Holdings reported by Anna Berkenblit for ImmunoGen, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 113,935 $3,377,033 $29.64 30 Jun 2023 Direct
Restricted Stock Unit 63,400 $1,863,960 $29.40 03 Feb 2023 Direct Common Stock
Stock Option (right to buy) 256,300 $1,330,197 $5.19 03 Feb 2023 Direct Common Stock

Transactions reported by Anna Berkenblit for ImmunoGen, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.